
POET Technologies Inc. (CVE:PTK – Free Report) – Equities research analysts at Zacks Research issued their Q2 2026 EPS estimates for shares of POET Technologies in a research note issued on Monday, June 1st. Zacks Research analyst L. Thompson anticipates that the company will earn ($0.11) per share for the quarter. The consensus estimate for POET Technologies’ current full-year earnings is ($0.80) per share. Zacks Research also issued estimates for POET Technologies’ Q3 2026 earnings at ($0.10) EPS and Q4 2026 earnings at ($0.07) EPS.
POET Technologies Price Performance
Shares of PTK opened at C$7.38 on Friday. POET Technologies has a fifty-two week low of C$3.57 and a fifty-two week high of C$10.53. The firm’s 50 day moving average price is C$7.38 and its 200 day moving average price is C$7.38. The company has a market cap of C$669.51 million, a P/E ratio of -9.11 and a beta of 0.82. The company has a quick ratio of 5.08, a current ratio of 1.89 and a debt-to-equity ratio of 14.84.
Insider Buying and Selling
POET Technologies Company Profile
POET Technologies Inc designs, develops, manufactures, and sells discrete and integrated opto-electronic solutions in Canada, the United States, Singapore, and China. The company offers integration solutions based on the POET Optical Interposer, a novel platform that allows the seamless integration of electronic and photonic devices into a single multi-chip module using advanced wafer-level semiconductor manufacturing techniques. It also develops photonic integrated components. The company serves the data center, telecommunications, Internet of things and industrial sensing, automotive LIDAR, optical coherence tomography for medical devices, and virtual reality systems markets.
See Also
- Five stocks we like better than POET Technologies
- Buy the Dip? Broadcom’s AI Moat Is Wider Than Ever
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
Receive News & Ratings for POET Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for POET Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
